Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issues
This issue
25-3
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
25-3
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #26880
advertisement
Konstas AG
9
Showing records 1 to 9 |
Display all abstracts from
Konstas AG
127117
Functionally deficient UBOX5 variants and primary angle-closure glaucoma
Li Z
Nature communications
2025; 16: 7620
127743
A Study of 24-h Efficacy and Safety of Sepetaprost vs. Latanoprost in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension
Konstas AG
Advances in Therapy
2025; 42: 3810-3825
127117
Functionally deficient UBOX5 variants and primary angle-closure glaucoma
Chng WL
Nature communications
2025; 16: 7620
127743
A Study of 24-h Efficacy and Safety of Sepetaprost vs. Latanoprost in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension
Garhöfer G; Lübke J
Advances in Therapy
2025; 42: 3810-3825
127117
Functionally deficient UBOX5 variants and primary angle-closure glaucoma
Liu Z; Do T
Nature communications
2025; 16: 7620
127743
A Study of 24-h Efficacy and Safety of Sepetaprost vs. Latanoprost in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension
Voykov B
Advances in Therapy
2025; 42: 3810-3825
127117
Functionally deficient UBOX5 variants and primary angle-closure glaucoma
Nakano M
Nature communications
2025; 16: 7620
127743
A Study of 24-h Efficacy and Safety of Sepetaprost vs. Latanoprost in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension
Ropo A
Advances in Therapy
2025; 42: 3810-3825
127117
Functionally deficient UBOX5 variants and primary angle-closure glaucoma
Chen LJ; Loo Y; Loo Y; Chan ASY; Topouzis F; Nongpiur ME; Ozaki M; Nakano S; Kubota T; Perera SA; Husain R; Wong TTL; Cheng CY; Ho CL; Abu-Amero K; Wong HT; Melo MB; Hien NDTN; Van Trinh N; Huong NTT; Azhany Y; Perez-Grossmann R; Chan PP; Stuart KV; Biradar MI; Szabo A; Szabo A; Anastasopoulos E; Giannoulis DA; Ntonti P; Papakonstantinou E; Lambropoulos A; Chatzikyriakidou A; Kilintzis V; Ayub H; Micheal S; Aung YY; Leuenberger EU; Fea A; Mon NN; Anajao A; Bi X; Kok YJ; Chong RS; Boey PY; Tan DZJ; Sin WWL; Chowbay B; Khaing CC; Aung YM; Reyes RD; Panagiotou ES; Mikropoulos DG; Voudouragkaki IC; Panos GD; Xie Z; Chen XY; Lim YT; Meah WY; Lee YS; Ho CEH; Yeo PMX; Ikeda Y; Tokuda Y; Tanaka M; Omi N; Ueno M; de Vasconcellos JPC; Costa VP; Abe RY; de Souza BB; Fong GB; Castro VV; Fujita R; Guevara-Fujita ML; Akhtar F; Ali M; Catacutan MAT; Felarca IR; Liao CS; Lavia C; Than HM; Oo KT; Soe-Kyaw PP; Frezzotti P; Pasutto F; Quino R; Minn-Din Z; Oo NL; Dallorto L; Set SH; Doan VH; Qamar R; Neto JM; Al-Obeidan S; Tham CC; Mori K; Sotozono C; Kinoshita S; Konstas AG; Liza-Sharmini AT; Zenteno JC; Do NH; Foster PJ; Tashiro K; Pang CP; Khawaja AP; Aung T; Wang Z; Khor CC
Nature communications
2025; 16: 7620
Issue
25-3
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept